首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Sackler Colloquium on Improving the Reproducibility of Scientific Research: Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data
【2h】

Sackler Colloquium on Improving the Reproducibility of Scientific Research: Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data

机译:Sackler学术讨论会旨在提高科学研究的可重复性:用于观察性医疗数据的人群水平效应估计研究的经验置信区间校准

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Observational healthcare data, such as electronic health records and administrative claims, offer potential to estimate effects of medical products at scale. Observational studies have often been found to be nonreproducible, however, generating conflicting results even when using the same database to answer the same question. One source of discrepancies is error, both random caused by sampling variability and systematic (for example, because of confounding, selection bias, and measurement error). Only random error is typically quantified but converges to zero as databases become larger, whereas systematic error persists independent from sample size and therefore, increases in relative importance. Negative controls are exposure–outcome pairs, where one believes no causal effect exists; they can be used to detect multiple sources of systematic error, but interpreting their results is not always straightforward. Previously, we have shown that an empirical null distribution can be derived from a sample of negative controls and used to calibrate P values, accounting for both random and systematic error. Here, we extend this work to calibration of confidence intervals (CIs). CIs require positive controls, which we synthesize by modifying negative controls. We show that our CI calibration restores nominal characteristics, such as 95% coverage of the true effect size by the 95% CI. We furthermore show that CI calibration reduces disagreement in replications of two pairs of conflicting observational studies: one related to dabigatran, warfarin, and gastrointestinal bleeding and one related to selective serotonin reuptake inhibitors and upper gastrointestinal bleeding. We recommend CI calibration to improve reproducibility of observational studies.
机译:观察性医疗保健数据,例如电子医疗记录和行政索赔,具有潜在地大规模估计医疗产品的影响。常常发现观察性研究是不可重复的,但是即使使用相同的数据库回答相同的问题,也会产生矛盾的结果。差异的来源之一是误差,误差既是由采样可变性引起的,又是系统性的(例如,由于混杂,选择偏差和测量误差)。通常仅对随机误差进行量化,但随着数据库的增大,其会收敛至零,而系统误差则与样本量无关而持续存在,因此,相对重要性会增加。阴性对照是暴露-结果对,其中有人认为不存在因果关系。它们可以用于检测系统错误的多种来源,但是解释其结果并不总是那么简单。以前,我们已经表明,可以从阴性对照样本中得出经验空值分布,并将其用于校准P值,从而说明了随机误差和系统误差。在这里,我们将这项工作扩展到置信区间(CI)的校准。配置项需要阳性对照,我们可以通过修改阴性对照来合成。我们表明,我们的CI校准可以恢复标称特性,例如95%CI可以覆盖95%的真实效果大小。我们进一步表明,CI校准可减少两对相互矛盾的观察性研究重复中的分歧:一项与达比加群,华法林和胃肠道出血有关,另一项与选择性5-羟色胺再摄取抑制剂和上消化道出血有关。我们建议CI校准以提高观察性研究的可重复性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号